Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study

Abstract

Only limited epidemiological evidence exists regarding the relationship between diabetic neuropathy and erectile dysfunction (ED) among Japanese patients with type 2 diabetes mellitus. To investigate the relationship between diabetic neuropathy and ED among Japanese patients with type 2 diabetes mellitus, a multicenter cross-sectional study was conducted in 287 male Japanese patients with type 2 diabetes mellitus, age (19–65 years). Diabetic neuropathy was diagnosed if the patients showed two or more of the following three characteristics: neuropathic symptoms, decreased or disappeared Achilles tendon reflex and/or abnormal vibration perception. ED, moderate to severe ED, and severe ED were defined as present when a subject had a Sexual Health Inventory for Men score <22, <12 and <8, respectively. The prevalence values of diabetic neuropathy and severe ED were 47.0 and 39.0%, respectively. Diabetic neuropathy was independently positively associated with severe ED, but not ED and moderate ED: the adjusted odds ratio was 1.90 (95% confidence interval: 1.08–3.38). No relationships were found between diabetic retinopathy or diabetic nephropathy and ED. Diabetic neuropathy is positively associated with severe erectile dysfunction among Japanese type 2 diabetes mellitus patients aged <65 years.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    CAS  Article  Google Scholar 

  2. 2

    Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB . Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002; 25: 1458–1463.

    Article  Google Scholar 

  3. 3

    Malavige LS, Levy JC . Erectile dysfunction in diabetes mellitus. J Sex Med 2009; 6: 1232–1247.

    Article  Google Scholar 

  4. 4

    Cho NH, Ahn CW, Park JY, Ahn TY, Lee HW, Park TS et al. Prevalence of erectile dysfunction in Korean men with type 2 diabetes mellitus. Diabet Med 2006; 23: 198–203.

    CAS  Article  Google Scholar 

  5. 5

    Zheng H, Fan W, Li G, Tam T . Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract 2006; 71: 313–319.

    Article  Google Scholar 

  6. 6

    Siu SC, Lo SK, Wong KW, Ip KM, Wong YS . Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet Med 2001; 18: 732–738.

    CAS  Article  Google Scholar 

  7. 7

    Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ . Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care 1996; 19: 135–141.

    CAS  Article  Google Scholar 

  8. 8

    Fedele D, Coscelli C, Santeusanio F, Bortolotti A, Chatenoud L, Colli E et al. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 1998; 21: 1973–1977.

    CAS  Article  Google Scholar 

  9. 9

    Sasaki H, Yamasaki H, Ogawa K, Nanjo K, Kawamori R, Iwamoto Y et al. Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res Clin Pract 2005; 70: 81–89.

    Article  Google Scholar 

  10. 10

    Yamasaki H, Ogawa K, Sasaki H, Nakao T, Wakasaki H, Matsumoto E et al. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract 2004; 66: s173–s177.

    Article  Google Scholar 

  11. 11

    Fukui M, Tanaka M, Okada H, Iwase H, Mineoka Y, Senmaru T et al. Five-item version of the international index of erectile function correlated with albuminuria and subclinical atherosclerosis in men with type 2 diabetes. J Atheroscler Thromb 2011; 18: 991–997.

    Article  Google Scholar 

  12. 12

    Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF . Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care 2003; 26: 1093–1099.

    Article  Google Scholar 

  13. 13

    De Berardis G, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH et al. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. Diabetes Care 2002; 25: 284–291.

    Article  Google Scholar 

  14. 14

    Vickers MA, Satyanarayana R . Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 2002; 14: 466–471.

    CAS  Article  Google Scholar 

  15. 15

    Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T . Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164–176.

    Article  Google Scholar 

  16. 16

    Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–992.

    CAS  Article  Google Scholar 

  17. 17

    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K et al. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Clin Exp Nephrol 2014; 18: 621–622.

    CAS  Article  Google Scholar 

  18. 18

    Yasuda H, Sanada M, Kitada K, Terashima T, Kim H, Sakaue Y et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract 2007; 77: S178–S183.

    CAS  Article  Google Scholar 

  19. 19

    Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    CAS  Article  Google Scholar 

  20. 20

    McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF . The prevalence of diabetic impotence. Diabetologia 1980; 18: 279–283.

    CAS  Article  Google Scholar 

  21. 21

    García-Malpartida K, Mármol R, Jover A, Gómez-Martínez MJ, Solá-Izquierdo E, Victor VM et al. Relationship between erectile dysfunction and silent myocardial ischemia in type 2 diabetic patients with no known macrovascular complications. J Sex Med 2011; 8: 2606–2616.

    Article  Google Scholar 

  22. 22

    Chuang YC, Chung MS, Wang PW, Lee WC, Chen CD, Chang HW et al. Albuminuria is an independent risk factor of erectile dysfunction in men with type 2 diabetes. J Sex Med 2012; 9: 1055–1064.

    CAS  Article  Google Scholar 

  23. 23

    Hecht MJ, Neundörfer B, Kiesewetter F, Hilz MJ . Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res 2001; 23: 651–654.

    CAS  Article  Google Scholar 

  24. 24

    Sima AA, Sugimoto K . Experimental diabetic neuropathy: an update. Diabetologia 1999; 42: 773–788.

    CAS  Article  Google Scholar 

  25. 25

    Yagihashi S, Yamagishi S, Wada R . Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract 2007; 77: S184–S189.

    CAS  Article  Google Scholar 

  26. 26

    Fedele D, Bortolotti A, Coscelli C, Santeusanio F, Chatenoud L, Colli E et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 2000; 29: 524–531.

    CAS  Article  Google Scholar 

  27. 27

    Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT et al. Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J Urol 2011; 185: 1828–1834.

    Article  Google Scholar 

  28. 28

    Jin Y, Kanamori A, Ito S, Matoba K, Miyakawa N, Kaneshige H et al. Cross-sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper. J Diabetes Investig 2012; 3: 252–258.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by JSPS KAKENHI Grants (217090583 and 23790697). We thank Eriko Kawamoto from Matsuyama City Hospital, Keiko Kikuchi from Ehime University and Eri Furukawa from Furukawa Clinic. JSPS KAKENHI Grants (217090583 and 23790697).

Author information

Affiliations

Authors

Corresponding author

Correspondence to S Furukawa.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Furukawa, S., Sakai, T., Niiya, T. et al. Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo Study. Int J Impot Res 29, 30–34 (2017). https://doi.org/10.1038/ijir.2016.40

Download citation

Further reading

Search

Quick links